-transparent.png){kind=logo}
OBJECTIVE Aim: To to increase the efficacy of the treatment of women diagnosed with complicated urogenital chlamydia infection based on the study of the immune status, clinical and pathogenetic features of the course, development and implementation of pathogenetically substantiated therapy methods. METHODS Materials and methods: Laboratory diagnostics of chlamydia infection was conducted with the use of direct immunofluorescence, enzyme immunoassay and cytological method. The dynamics of clinical symptoms was studied in the patients of Group I (64 women) who received Wobenzym in combination with Doxycycline and Group II (64 women) who were treated with conventional therapy (CT). RESULTS Results: Clinical effectiveness of the treatment of women in Groups I and II was analyzed. The treatment according to our developed method was well tolerated by all the patients. No manifestations of the disease exacerbation which could be associated with the inclusion of these drugs in the comprehensive treatment were noted. The insignificant effectiveness of our treatment in the examined patients with complicated urogenital chlamydia infection in Groups I and II was distributed as follows: only 1 (1.56%) woman (Group I) had an insignificant improvement in clinical manifestations after the treatment according to our method. An insignificant improvement in the clinical manifestations after the treatment with conventional therapy (Group II) was observed in 4 women constituting 6.25%. Unfortunately, a small percentage of women in Groups I and II with no changes in clinical symptoms after the treatment was observed. In particular, the absence of treatment effectiveness was noted in 3 (4.69%) women after the application of our method and in 6 women (9.38%) who were treated by the conventional therapy. Therefore, these women were prescribed an additional course of treatment. CONCLUSIONS Conclusions: The dynamics of clinical symptoms was found to be significantly more pronounced and fast in the patients of Group I compared to the patients in Group II who were treated with conventional therapy.
O P Kukhta, and
O D Aleksandruk, and
O V Neiko, and
I B Romash, and
I R Romash, and
N I Romash, and
Neogi Reevu
January 1982,
American journal of obstetrics and gynecology,
O P Kukhta, and
O D Aleksandruk, and
O V Neiko, and
I B Romash, and
I R Romash, and
N I Romash, and
Neogi Reevu
January 2003,
Urologiia (Moscow, Russia : 1999),
O P Kukhta, and
O D Aleksandruk, and
O V Neiko, and
I B Romash, and
I R Romash, and
N I Romash, and
Neogi Reevu
June 1989,
Akusherstvo i ginekologiia,
O P Kukhta, and
O D Aleksandruk, and
O V Neiko, and
I B Romash, and
I R Romash, and
N I Romash, and
Neogi Reevu
January 2009,
Advances in medical sciences,
O P Kukhta, and
O D Aleksandruk, and
O V Neiko, and
I B Romash, and
I R Romash, and
N I Romash, and
Neogi Reevu
July 1989,
Akusherstvo i ginekologiia,
O P Kukhta, and
O D Aleksandruk, and
O V Neiko, and
I B Romash, and
I R Romash, and
N I Romash, and
Neogi Reevu
January 2004,
Arkhiv patologii,
O P Kukhta, and
O D Aleksandruk, and
O V Neiko, and
I B Romash, and
I R Romash, and
N I Romash, and
Neogi Reevu
January 2000,
Voprosy virusologii,
O P Kukhta, and
O D Aleksandruk, and
O V Neiko, and
I B Romash, and
I R Romash, and
N I Romash, and
Neogi Reevu
January 1988,
Vestnik dermatologii i venerologii,
O P Kukhta, and
O D Aleksandruk, and
O V Neiko, and
I B Romash, and
I R Romash, and
N I Romash, and
Neogi Reevu
January 2002,
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
O P Kukhta, and
O D Aleksandruk, and
O V Neiko, and
I B Romash, and
I R Romash, and
N I Romash, and
Neogi Reevu
November 1982,
Canadian Medical Association journal,
